Sign Up Now to Download a Free Research Report on PTIE
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Pain Therapeutics
Pain Therapeutics shares plunged 49.62 percent on volume of over 5.0 million shares traded Friday to close at $2.68 a share. Shares of the company and Durect Corp. fell sharply after Pfizer Inc. stated it was reassessing partnership for the painkiller Remoxy. “Given the years of delay, additional cost incurred to bring the program to this point and development work left in the program, there will be much to consider,” Pfizer said in a letter.
Going forward ... (see research report)
Subscribe to News Feeds